Free Trial

Boston Scientific (BSX) Competitors

Boston Scientific logo
$97.84 +0.13 (+0.13%)
As of 01:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BSX vs. ALGN, HOLX, HQY, MMSI, AMN, CAH, DVA, ECL, HCA, and MDT

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Align Technology (ALGN), Hologic (HOLX), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cardinal Health (CAH), DaVita (DVA), Ecolab (ECL), HCA Healthcare (HCA), and Medtronic (MDT).

Boston Scientific vs. Its Competitors

Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

88.4% of Align Technology shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.7% of Align Technology shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Boston Scientific has a net margin of 13.55% compared to Align Technology's net margin of 11.04%. Boston Scientific's return on equity of 19.21% beat Align Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology11.04% 13.36% 8.32%
Boston Scientific 13.55%19.21%10.62%

Align Technology has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500.

Align Technology currently has a consensus price target of $182.67, suggesting a potential upside of 39.15%. Boston Scientific has a consensus price target of $120.71, suggesting a potential upside of 23.37%. Given Align Technology's higher possible upside, research analysts clearly believe Align Technology is more favorable than Boston Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
2 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.41
Boston Scientific
0 Sell rating(s)
2 Hold rating(s)
23 Buy rating(s)
2 Strong Buy rating(s)
3.00

In the previous week, Boston Scientific had 7 more articles in the media than Align Technology. MarketBeat recorded 32 mentions for Boston Scientific and 25 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.24 beat Align Technology's score of 0.35 indicating that Boston Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
8 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Boston Scientific
25 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Boston Scientific has higher revenue and earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.00B2.38$421.36M$5.9322.14
Boston Scientific$18.49B7.84$1.85B$1.6858.24

Summary

Boston Scientific beats Align Technology on 13 of the 17 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$145.05B$10.60B$6.15B$21.77B
Dividend YieldN/A1.91%5.73%3.62%
P/E Ratio58.2720.1484.9829.91
Price / Sales7.8426.69574.6697.86
Price / Cash26.3625.0737.3924.26
Price / Book6.553.4612.454.65
Net Income$1.85B$208.83M$3.32B$1.01B
7 Day Performance0.58%-1.31%0.28%-0.24%
1 Month Performance-1.14%2.34%10.12%0.84%
1 Year Performance12.44%-7.02%72.36%12.29%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BSX
Boston Scientific
4.8777 of 5 stars
$97.84
+0.1%
$120.71
+23.4%
+12.7%$145.05B$18.49B58.2753,000Positive News
Upcoming Earnings
ALGN
Align Technology
4.8018 of 5 stars
$129.54
+3.0%
$196.67
+51.8%
-41.4%$9.39B$3.96B21.8420,945Analyst Forecast
Analyst Revision
HOLX
Hologic
4.7288 of 5 stars
$65.51
-3.3%
$80.15
+22.4%
-18.0%$14.57B$4.03B27.187,063Positive News
HQY
HealthEquity
4.2106 of 5 stars
$93.23
+3.0%
$121.31
+30.1%
+10.4%$8.03B$1.27B56.503,120
MMSI
Merit Medical Systems
4.7151 of 5 stars
$79.43
+0.6%
$107.50
+35.3%
-15.9%$4.70B$1.36B40.327,400News Coverage
Analyst Forecast
AMN
AMN Healthcare Services
4.0513 of 5 stars
$19.14
+5.4%
$23.08
+20.6%
-49.3%$733.45M$2.98B-2.462,968Analyst Forecast
Analyst Revision
CAH
Cardinal Health
4.9147 of 5 stars
$154.26
-1.7%
$166.00
+7.6%
+39.0%$36.65B$222.58B23.9257,700Positive News
DVA
DaVita
4.6992 of 5 stars
$123.89
-0.1%
$155.25
+25.3%
-23.5%$8.86B$13.16B12.1876,000Analyst Forecast
ECL
Ecolab
4.8461 of 5 stars
$270.16
-0.7%
$292.29
+8.2%
+6.0%$76.62B$15.72B36.0748,000Positive News
Analyst Forecast
HCA
HCA Healthcare
4.7749 of 5 stars
$410.71
-1.1%
$422.31
+2.8%
+4.8%$96.10B$70.60B17.26316,000Analyst Forecast
MDT
Medtronic
4.8637 of 5 stars
$95.63
+0.2%
$102.41
+7.1%
+6.1%$122.66B$33.54B26.3495,000Trending News
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:BSX) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners